Human MIP-3 alpha PharmaGenie ELISA Kit (SBRS0887)

Quantitative measurement of human CCL20 (also known as MIP-3α, LARC, or Exodus-1) — a small inflammatory chemokine that selectively engages the CCR6 G-protein-coupled receptor to drive chemotaxis of B-lymphocytes, T-helper 17 cells, and dendritic cells toward mucosal and inflamed tissues — is enabled by the Assay Genie Human MIP-3 alpha PharmaGenie ELISA Kit. The microplate immunoassay supports investigators working in mucosal immunity, inflammatory bowel disease, psoriasis, rheumatoid arthritis, and tumor microenvironment research, allowing quantification of the chemokine across cell culture supernatants, cell lysates, plasma or serum specimens, and tissue lysates. The 96-assay kit format supports full standard curves alongside unknown sample replicates and is suitable for in vitro research workflows. Researchers apply this ELISA to monitor CCR6 ligand concentrations as biomarkers of disease activity, mucosal inflammation, immune cell trafficking, or therapeutic response in autoimmune, infectious disease, and oncology models.